Glycomics Market Research Report Information By Product (Enzymes [Glycosidases, Neuraminidases, Glycosyltransferases, Sialyltransferases, and Others], Kits [Glycan Labeling Kits, Glycan Purification Kits, Glycan Release Kits, and Others], Reagents [Glycoproteins, Monosaccharides, Oligosaccharides, and Others], and Instruments [Mass Spectrometers, HPLC, MALDI-TOF, Array Systems, and Others]), By Application (Drug Discovery & Development, Diagnostics, and Others), By End-use (Academic & Research Institutes, Pharmaceutical & Biotechnology Comp

Global Glycomics Market Overview

The Glycomics Market was valued at USD 1.9 billion in 2022. The Glycomics market industry is projected to grow from USD 2.20 billion in 2023 to USD 7.11 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 15.80% during the forecast period (2024 - 2032). Glycans' emergence as biomarkers and the use of glycomics in personalized medicine are the key market drivers augmenting market growth.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Glycomics Market Trends

• Growth of research & academic institutions is driving the market growth

The growth and development of academic and research institutes studying glycomics, which has many applications in the rapid generation of pharmaceuticals, vaccines, and precision treatments, are expected to be the main driving forces behind the global market. Revenue streams are created through expanding partnerships between research institutions and important market participants to fund biomedical and biochemical research activities. Manufacturers in the Glycomics Market can grow by extending their relationship with research organizations in the pharmaceutical industry to outsource research and development tasks in order to keep ahead of the competition. The Glycomics Market is influenced by an increase in the cooperation between industry players and research institutions to investigate proteomics and glycomics in order to find treatments for genetic illnesses.

Furthermore, the development of innovative glycomics and glycobiology techniques has been made possible by growing funding from public and nonprofit institutions. Industry penetration has also been accelerated by continuing financing initiatives to investigate the possibilities of glycomics in personalized medicine and diagnostics. For example, in July 2020, USD 16.3 million was awarded to GlycoNet, a Canadian Network of Centers of Excellence, to support its glycomic research activities for human health benefits. GlycoNet was given this grant because it possesses the most robust collection of glycan researchers in the field of glycobiology.

The market for glycomics has experienced rapid expansion due to an increased focus on glycobiology research. New tool development has been made possible by large investments in this field by academic researchers. Many scientists believe that glycans are crucial to biological processes and studying them broadens our understanding of biology without requiring us to specialize in glycobiology. This offers a broad range of possible uses for glycan analysis. For example, in September 2021, researchers at the University of California, San Diego, created a platform that enables the analysis of glycomics information through the use of artificial intelligence and other machine learning techniques. The researchers dubbed the method GlyCompare. It requires a systems-level perspective that takes into consideration the common glycan biosynthesis processes both within and between samples. The goal of this strategy is to produce clinical advances in cancer diagnosis. Thus, driving the Glycomics market revenue.

Glycomics Market Segment Insights

Glycomics Product Insights

The Glycomics Market segmentation, based on product, includes enzymes (glycosidases, neuraminidases, glycosyltransferases, sialyltransferases, and others), kits (glycan labeling kits, glycan purification kits, glycan release kits, and others), reagents (glycoproteins, monosaccharides, oligosaccharides, and others), and instruments (mass spectrometers, HPLC, MALDI-TOF, array systems, and others). In 2023, the enzymes segment dominated the market. The market is expanding due to many factors, such as the extensive use of enzymes in glycan-based research, drug development, and diagnostics. Numerous studies reveal the epigenetic control of these enzymes in different cancer cells, leading to the creation of glycan structures—one of the main strategies adopted by malignant cells to thwart host immune responses. To learn more about the roles of particular glycan cancer epitopes, scientists have created genetically altered cell models. Overexpression of glycosyltransferases is one example of this, leading to the production and characterization of cancer-associated epitopes, including STn, T, Tn, and ST.

The instruments category is anticipated to be the fastest growing. The increased use of equipment in drug discovery and diagnostic testing is the primary cause of its rapid expansion. The development of the market is also supported by improvements in accuracy and turnaround time, as well as increased efforts by industry participants to produce cutting-edge glycan-based devices.

Glycomics Application Insights

The Glycomics Market segmentation, based on application, includes drug discovery & development, diagnostics, and others. The drug discovery & development category leads the market. This is mainly because more R&D projects are being undertaken, and the government is investing more money in glycomics and proteome research. Novel therapeutic targets can now be identified by utilizing sophisticated glycan profiling approaches and analytical tools, which were made possible by advances in glycobiology research.

During the projection period, the glycomics market’s diagnostics segment is anticipated to grow at the fastest rate. The high frequency of chronic illnesses, the growing need for individualized treatment, and developments in glycan analysis technologies will contribute to the expansion of this market. Glycan-based biomarkers' detection specificity was enhanced by developments in glycan analysis, including lectin-based assays, mass spectrometry, and glycosyl microarrays.

Figure 1:  Glycomics Market, by Application, 2023 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Glycomics End-user Insights

The Glycomics Market segmentation, based on end-use, includes academic & research institutes, pharmaceutical & biotechnology companies, biopharmaceutical companies, and CROs. The market is led by the academic & research institutes category. The widespread use of glycan structure data analysis by research centers is responsible for this substantial portion. Another reason driving the segment's rise is the growing desire for the field of glycobiology for training and education. Glycomics products also have a broad range of applications in immunology, cell biology, biochemistry, biomedical research, and drug discovery & development, which is anticipated to drive market expansion in the near future.

The biopharmaceutical companies segment of the glycomics market is predicted to develop at the quickest rate over the projected period. Expanding efforts by biopharmaceutical companies to discover novel medicines and significant investments made by market participants to use glycan-based techniques in drug development are expected to promote segment expansion.

Glycomics Regional Insights

By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American glycomics market area will dominate this market, owing to the existence of significant companies, improved healthcare infrastructure, developed economies, and their varied strategic activities collectively driving the industry. Regional industrial growth is also being aided by the rising demand for innovative therapies and the government's increased financing of research and development. Canada is North America's fastest-growing market. Additionally, the US market in North America has the largest market share.

Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, and South Korea.

Figure 2: Glycomics Market Share By Region 2023 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe glycomics market accounts for the second-largest market share due to the existence of top-notch universities and research institutes, along with a high disease burden and a supportive research infrastructure, which are anticipated to stimulate the regional market. Furthermore, biopharmaceutical businesses and academic institutions are now able to undertake more comprehensive glycomics investigations and investigate possible applications in healthcare due to the availability of research grants and financing programs. Further, the German glycomics market held the largest market share, and the UK glycomics market was the fastest growing market in the European region.

The Asia-Pacific glycomics market is expected to grow at the fastest CAGR from 2024 to 2032. By sponsoring fundamental research projects, a number of countries in the Asia Pacific area are addressing the region's lack of qualified workers in the glycoscience field. For example, China's National High-Tech R&D Program and National Basic Research Program are devoted to biotechnology, information technology, and life sciences research and development. Moreover, China’s glycomics market held the largest market share, and the Indian glycomics market was the fastest growing market in the Asia-Pacific region.

Glycomics Key Market Players & Competitive Insights

The industry's top companies will keep investing heavily in R&D to expand their product lines, which will propel the growth of the glycomics market. Contractual agreements, mergers and acquisitions, increased investments, collaboration with other companies, and the production of new products are examples of significant market developments. In order to increase their global reach, market players are also taking a variety of calculated risks. In order to survive and expand in a more competitive and dynamic market, the glycomics industry must offer reasonably priced products.

Local production to save operating costs is one of the primary tactics used by manufacturers in the Glycomics Market to benefit consumers and grow the market sector. Some of the biggest benefits to biopharmaceutical companies in recent years have come from the glycomics sector. Major players in the glycomics market, including Thermo Fisher Scientific, Inc., Merck KgaA, Agilent Technologies Inc., Bruker, New England Biolabs, Shimadzu Corporation, Waters Corporation, Takara Bio Inc., Asparia Glycomics, RayBiotech Life, Inc., and others, are attempting to increase market demand by investing in research and development operations.

Thermo Fisher Scientific Inc. is the industry leader in delivering services to science worldwide, with an approximate yearly sale of $40 billion. The company's goal is to empower its clients to improve the quality, safety, and cleanliness of the environment. The organization is available to assist its clients in accelerating life sciences research, resolving challenging analytical problems, boosting laboratory productivity, enhancing patient health through diagnostics, or developing and producing game-changing treatments. The company's global team, which includes the industry-leading brands Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD, provides an unparalleled blend of cutting-edge technology, ease of purchase, and pharmaceutical services. Thermo Fisher Scientific stated on March 25, 2019, that it had acquired Brammer Bio, a gene therapy-focused Contract Development and Manufacturing Organization (CDMO). The objective of this acquisition was to fortify Thermo Fisher's CDMO capabilities and expand its product options in the gene therapy sector.

Customers of Agilent are developing novel approaches to cancer therapy, guaranteeing the safety and quality of food, water, air, and medications, identifying novel pharmacological treatments, studying infectious diseases, and developing alternative energy sources for a cleaner environment. With their extensive variety of products and services, Agilent has them covered from beginning to end. People at Agilent advance science globally via discoveries, technologies, and services. For usage in and outside of laboratories, Agilent teams develop and produce a broad range of cutting-edge analytical, research, and diagnostic instruments and solutions. Additionally, clients can completely optimize their laboratories and resources with the assistance of Agilent's technical teams and CrossLab because of the company's unique experience. This allows customers to concentrate more on what matters—bringing amazing research to life. Agilent Technologies made $6.85 billion in revenue in the 2022 fiscal year. Agilent Technologies paid up to USD695 million to purchase Resolution Bioscience, a provider of genomic sequencing technology, on March 2, 2021. Agilent made this acquisition in order to expand its line of molecular diagnostics products, which includes liquid biopsy-based cancer diagnosis.

Key Companies in the Glycomics market include

• Thermo Fisher Scientific, Inc.


• Merck KgaA


• Agilent Technologies Inc.


• Bruker


• New England Biolabs


• Shimadzu Corporation


• Waters Corporation


• Takara Bio Inc.


• Asparia Glycomics


• RayBiotech Life, Inc.

Glycomics Industry Developments

April 2022: The US-based Bruker Corporation purchased IonSense in order to increase the usage of DART mass spectrometers.

April 2021: To create drugs for the treatment of genetic disorders, GlycoNet (Canada) and BridgeBio Pharma Inc. (US) teamed up to conduct glycobiology research.

Glycomics Market Segmentation

Glycomics Product Outlook

• Enzymes
  
  
  
  • Glycosidases
  
  
  • Neuraminidases
  
  
  • Glycosyltransferases
  
  
  • Sialyltransferases
  
  
  • Others
  
  
  
  


• Kits
  
  
  
  • Glycan Labeling Kits
  
  
  • Glycan Purification Kits
  
  
  • Glycan Release Kits
  
  
  • Others
  
  
  
  


• Reagents
  
  
  
  • Glycoproteins
  
  
  • Monosaccharides
  
  
  • Oligosaccharides
  
  
  • Others
  
  
  
  


• Instruments
  
  
  
  • Mass Spectrometers
  
  
  • HPLC
  
  
  • MALDI-TOF
  
  
  • Array Systems
  
  
  • Others
  
  
  
  

Glycomics Application Outlook

• Drug Discovery & Development


• Diagnostics


• Others

Glycomics End-user Outlook

• Academic & Research Institutes


• Pharmaceutical & Biotechnology Companies


• Biopharmaceutical Companies


• CROs

Glycomics Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America